Sudden Cardiac Death - Screening Of Risk Factors (SCD-SOS)

June 9, 2017 updated by: Rui Providência, University of Coimbra

Sudden Cardiac Death: Evaluation of a New Strategy to Identify Young Adults at Risk

The investigators have created a way of quickly collecting information in a large scale young population regarding the presence of some severity indicators that may allow us to classify them into: seemingly "low risk" and possible "elevated risk" for the presence of heart disease. It would have to be a short questionnaire, in order to receive a great adherence but that could simultaneously provide precise information, with an adequate description of symptoms and warning signs, in a way that a triage in the young adult population could be performed in the general young adult population in order to select individuals with an indication for personalized clinical evaluation and possible need of complementary diagnostic means. Based on this premise the investigators have developed a fast-response questionnaire named the Sudden Cardiac Death Screening Of risk factorS (SCD-SOS). This questionnaire has already been tested in a population of approximately 1500 young adults, and some changes have been introduced in order to refine its performance.

To best of the investigators knowledge, there are no large scale European surveys estimating the prevalence of cardiac disease and associated clinical symptoms in a non-selected (non-athlete) population of this age group.

Purpose: To screen a young adult population from central regional of Portugal for heart disease possibly associated to a high risk of Sudden Cardiac Death (SCD).

To determine the national prevalence of clinical symptoms of heart disease and of heart disease with increased risk for SCD in this age group.

To detect young adults in risk of SCD and with an indication for evaluation by a cardiologist, and possible need of:

  • medical treatment
  • electrophysiologic (EP) study and percutaneous ablation
  • an implantable cardiovertor defibrillator
  • a pacemaker
  • other type of specialized cardiac intervention

Study Overview

Study Type

Observational

Enrollment (Actual)

15351

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • State...
      • Coimbra, State..., Portugal, 3000
        • Unidade Móvel - Tenda de Rastreio - SCDSOS

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

12 years to 40 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Recruitment will include mainly university students but also young adults involved in sport practice (professional, semi-professional and amateur athletes) or in other activities (sales, industry, etc). This way, the places for sample collection will the university departments or technical schools, students associations and other places that gather university students, shopping centers, gyms, sports venues, factories in the city surroundings. Information collection in these places will be performed under the authorization of proper entities.

Description

Inclusion Criteria:

  • 12 to 40 years of age
  • Providing an informed consent

Exclusion Criteria:

  • Failure to meet any of the aforementioned inclusion criteria

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
young adults - Central region of Portugal

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Type 1 electrocardiogram
Time Frame: baseline

Presence of ECG changes suggestive of cardiac disease associated with an increased risk of sudden cardiac death. Definition present in:

Corrado D et al. Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur Heart J 2010;31:243-259

baseline
Clinical History - Red Flag
Time Frame: Baseline

Presence of answers concerning symptoms or past family history that are known to be associated with increased risk of sudden cardiac death:

e.g. effort syncope, syncope with fast palpitations prodrome, know high-risk cardiac disease, history of sudden cardiac death in first or second degree relative

Baseline
all-cause mortality
Time Frame: First 20 years after enrollement
occurrence of death of any cause in the participant
First 20 years after enrollement
Cardiovascular death
Time Frame: First 20 years after enrollement
Occurrence of death of cardiovascular etiology during follow-up.
First 20 years after enrollement

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Rui Providência, M.D. M.Sc., Coimbra's Hospital Centre and University; Faculty of Medicine, University of Coimbra, Portugal

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

February 1, 2012

Primary Completion (Actual)

May 1, 2013

Study Completion (Anticipated)

December 1, 2017

Study Registration Dates

First Submitted

April 27, 2013

First Submitted That Met QC Criteria

May 2, 2013

First Posted (Estimate)

May 3, 2013

Study Record Updates

Last Update Posted (Actual)

June 12, 2017

Last Update Submitted That Met QC Criteria

June 9, 2017

Last Verified

June 1, 2017

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiomyopathies

Clinical Trials on ECG and survey screening

Subscribe